Population-Pharmacokinetic Modeling of Tildrakizumab (MK-3222), an Anti-Interleukin-23-p19 Monoclonal Antibody, in Healthy Volunteers and Subjects with Psoriasis

2019 ◽  
Vol 58 (8) ◽  
pp. 1059-1068 ◽  
Author(s):  
Petra Jauslin ◽  
Pooja Kulkarni ◽  
Hanbin Li ◽  
Suresh Vatakuti ◽  
Azher Hussain ◽  
...  
2016 ◽  
Vol 33 (7) ◽  
pp. 1657-1670 ◽  
Author(s):  
Maiara Cássia Pigatto ◽  
Bibiana Verlindo de Araujo ◽  
Bruna Gaelzer Silva Torres ◽  
Stephan Schmidt ◽  
Paolo Magni ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document